“The Significance Of “Kalmeghadi Avaleha” As A Therapeutic Intervention In Childhood Sickle Cell Disease / Sickle Cell Anemia: A Case Report”
Main Article Content
Abstract
INTRODUCTION:
Red blood cells with Sickle Cell Disease, are affected by an autosomal recessive genetic disease that results in an abnormal crescent shape that resembles a "Sickle Shape" and reduces the life of the cells. Sickle cell disease is a hereditary disease with a high rate of morbidity and mortality. The quality of life of patients with sickle cell disease is significantly impacted by their condition's chronic nature and acute pain. At this time, there is no complete treatment for the illness other than genetic transplants. Ayurvedic disease entities such as Pandu Roga share most clinical features with SCA/SCD, but there is no direct correlation between the two. From an Ayurvedic perspective, Sickle cell disease is Asadhya in nature and an Adibala pravrutta vyadhi. Society benefits when a medication and the patient's efforts together help a patient maintain their health and quality of life. The disease Pandu, which shares similarities with various forms of anemia, is defined by Ayurveda. The main symptoms of Pandu are fatigue and appetite loss. Consequently, Ayurveda emphasizes a diet fortified with medicines, and diet has a clear role in sickle cell disease.
METHODS:
In this study, Kalmegha, Sharpunkha, Vikantaka, Punarnava, Amalaki, Dadima and Pippali as a medicinal formulation and given to patients with sickle cell disease.
RESULTS:
There is significant relief in the symptoms of crisis, pain, fatigue, and loss of appetite in the patient treated with Kalmeghadi Avaleha as a Prescribed medicine.
DISCUSSION:
A specific Rakta Pitta Dosha Shaman with “Kalmeghadi Avaleha” can be used to treat Sickle Cell Disease, also known as Beeja-Dustijanya Vata Dosha pradhan Vyadhi. As it is a genetic disease medication can't cure the disease, they can help manage its symptoms.
CONCLUSION:
Ayurveda is a science that offers a foundation for various formula-based medication treatments for crises or symptoms associated with sickle cell disease.